Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Borrelia miyamotoi infection leads to cross-reactive antibodies to the C6 peptide in mice and men.

Koetsveld J, Platonov AE, Kuleshov K, Wagemakers A, Hoornstra D, Ang W, Szekeres S, van Duijvendijk GLA, Fikrig E, Embers ME, Sprong H, Hovius JW.

Clin Microbiol Infect. 2019 Aug 9. pii: S1198-743X(19)30418-5. doi: 10.1016/j.cmi.2019.07.026. [Epub ahead of print]

2.

Author Correction: Immune evasion of Borrelia miyamotoi: CbiA, a novel outer surface protein exhibiting complement binding and inactivating properties.

Röttgerding F, Wagemakers A, Koetsveld J, Fingerle V, Kirschfink M, Hovius JW, Zipfel PF, Wallich R, Kraiczy P.

Sci Rep. 2019 May 2;9(1):7056. doi: 10.1038/s41598-019-42948-7.

3.

Borrelia miyamotoi Disease in an Immunocompetent Patient, Western Europe.

Hoornstra D, Koetsveld J, Sprong H, Platonov AE, Hovius JW.

Emerg Infect Dis. 2018 Sep;24(9):1770-1772. doi: 10.3201/eid2409.180806.

4.

In Vitro Antimicrobial Susceptibility of Clinical Isolates of Borrelia miyamotoi.

Koetsveld J, Manger A, Hoornstra D, Draga RO, Oei A, Kolyasnikova NM, Toporkova MG, Sarksyan DS, Wagemakers A, Platonov AE, Hovius JW.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e00419-18. doi: 10.1128/AAC.00419-18. Print 2018 Jul.

5.

Serodiagnosis of Borrelia miyamotoi disease by measuring antibodies against GlpQ and variable major proteins.

Koetsveld J, Kolyasnikova NM, Wagemakers A, Stukolova OA, Hoornstra D, Sarksyan DS, Toporkova MG, Henningsson AJ, Hvidsten D, Ang W, Dessau R, Platonov AE, Hovius JW.

Clin Microbiol Infect. 2018 Dec;24(12):1338.e1-1338.e7. doi: 10.1016/j.cmi.2018.03.009. Epub 2018 Mar 14.

PMID:
29550499
6.

Whole-Genome Sequencing of Six Borrelia miyamotoi Clinical Strains Isolated in Russia.

Kuleshov KV, Koetsveld J, Goptar IA, Markelov ML, Kolyasnikova NM, Sarksyan DS, Toporkova MG, Kirdyashkina NP, Shipulin GA, Hovius JW, Platonov AE.

Genome Announc. 2018 Jan 4;6(1). pii: e01424-17. doi: 10.1128/genomeA.01424-17.

7.

[Clinical presentation of Ixodes tick-borne borreliosis caused by Borrelia miyamotoi in the context of an immune response to the pathogen].

Platonov AE, Toporkova MG, Kolyasnikova NM, Stukolova OA, Dolgova AS, Brodovikova AV, Makhneva NA, Karan LS, Koetsveld J, Shipulin GA, Maleev VV.

Ter Arkh. 2017;89(11):35-43. doi: 10.17116/terarkh2017891135-43. Russian.

PMID:
29260744
8.

In Vitro Susceptibility of the Relapsing-Fever Spirochete Borrelia miyamotoi to Antimicrobial Agents.

Koetsveld J, Draga ROP, Wagemakers A, Manger A, Oei A, Visser CE, Hovius JW.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00535-17. doi: 10.1128/AAC.00535-17. Print 2017 Sep.

9.

Immune evasion of Borrelia miyamotoi: CbiA, a novel outer surface protein exhibiting complement binding and inactivating properties.

Röttgerding F, Wagemakers A, Koetsveld J, Fingerle V, Kirschfink M, Hovius JW, Zipfel PF, Wallich R, Kraiczy P.

Sci Rep. 2017 Mar 22;7(1):303. doi: 10.1038/s41598-017-00412-4. Erratum in: Sci Rep. 2019 May 2;9(1):7056.

10.

Development and optimization of an in vitro cultivation protocol allows for isolation of Borrelia miyamotoi from patients with hard tick-borne relapsing fever.

Koetsveld J, Kolyasnikova NM, Wagemakers A, Toporkova MG, Sarksyan DS, Oei A, Platonov AE, Hovius JW.

Clin Microbiol Infect. 2017 Jul;23(7):480-484. doi: 10.1016/j.cmi.2017.01.009. Epub 2017 Jan 18.

11.

Variable Major Proteins as Targets for Specific Antibodies against Borrelia miyamotoi.

Wagemakers A, Koetsveld J, Narasimhan S, Wickel M, Deponte K, Bleijlevens B, Jahfari S, Sprong H, Karan LS, Sarksyan DS, van der Poll T, Bockenstedt LK, Bins AD, Platonov AE, Fikrig E, Hovius JW.

J Immunol. 2016 May 15;196(10):4185-95. doi: 10.4049/jimmunol.1600014. Epub 2016 Apr 13.

12.

Serological and molecular evidence for spotted fever group Rickettsia and Borrelia burgdorferi sensu lato co-infections in The Netherlands.

Koetsveld J, Tijsse-Klasen E, Herremans T, Hovius JW, Sprong H.

Ticks Tick Borne Dis. 2016 Mar;7(2):371-7. doi: 10.1016/j.ttbdis.2015.12.010. Epub 2015 Dec 17.

PMID:
26739030
13.

Ixodes scapularis dystroglycan-like protein promotes Borrelia burgdorferi migration from the gut.

Coumou J, Narasimhan S, Trentelman JJ, Wagemakers A, Koetsveld J, Ersoz JI, Oei A, Fikrig E, Hovius JW.

J Mol Med (Berl). 2016 Mar;94(3):361-70. doi: 10.1007/s00109-015-1365-0. Epub 2015 Nov 23.

14.

In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1.

Holleboom AG, Jakulj L, Franssen R, Decaris J, Vergeer M, Koetsveld J, Luchoomun J, Glass A, Hellerstein MK, Kastelein JJ, Hovingh GK, Kuivenhoven JA, Groen AK, Turner SM, Stroes ES.

J Lipid Res. 2013 Jul;54(7):1964-71. doi: 10.1194/jlr.P028449. Epub 2013 May 6.

15.

A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption.

Allard SD, De Keersmaecker B, de Goede AL, Verschuren EJ, Koetsveld J, Reedijk ML, Wylock C, De Bel AV, Vandeloo J, Pistoor F, Heirman C, Beyer WE, Eilers PH, Corthals J, Padmos I, Thielemans K, Osterhaus AD, Lacor P, van der Ende ME, Aerts JL, van Baalen CA, Gruters RA.

Clin Immunol. 2012 Mar;142(3):252-68. doi: 10.1016/j.clim.2011.10.010. Epub 2011 Nov 16.

PMID:
22177848
16.

ATP-binding cassette transporter G1 and high-density lipoprotein promote endothelial NO synthesis through a decrease in the interaction of caveolin-1 and endothelial NO synthase.

Terasaka N, Westerterp M, Koetsveld J, Fernández-Hernando C, Yvan-Charvet L, Wang N, Sessa WC, Tall AR.

Arterioscler Thromb Vasc Biol. 2010 Nov;30(11):2219-25. doi: 10.1161/ATVBAHA.110.213215. Epub 2010 Aug 26.

17.

Increased atherosclerosis in mice with vascular ATP-binding cassette transporter G1 deficiency--brief report.

Westerterp M, Koetsveld J, Yu S, Han S, Li R, Goldberg IJ, Welch CL, Tall AR.

Arterioscler Thromb Vasc Biol. 2010 Nov;30(11):2103-5. doi: 10.1161/ATVBAHA.110.212985. Epub 2010 Aug 12.

18.

Cholesteryl ester transfer protein inhibition: a dysfunctional endothelium.

Westerterp M, Koetsveld J, Tall AR.

J Cardiovasc Pharmacol. 2010 May;55(5):456-8. doi: 10.1097/FJC.0b013e3181dc61d4. No abstract available. Erratum in: J Cardiovasc Pharmacol. 2010 Jul;56(1):110.

PMID:
20351566
19.

Carriers of loss-of-function mutations in ABCA1 display pancreatic beta-cell dysfunction.

Vergeer M, Brunham LR, Koetsveld J, Kruit JK, Verchere CB, Kastelein JJ, Hayden MR, Stroes ES.

Diabetes Care. 2010 Apr;33(4):869-74. doi: 10.2337/dc09-1562. Epub 2010 Jan 12.

20.

Cathepsin L, target in cancer treatment?

Lankelma JM, Voorend DM, Barwari T, Koetsveld J, Van der Spek AH, De Porto AP, Van Rooijen G, Van Noorden CJ.

Life Sci. 2010 Feb 13;86(7-8):225-33. doi: 10.1016/j.lfs.2009.11.016. Epub 2009 Nov 30. Review.

PMID:
19958782

Supplemental Content

Loading ...
Support Center